FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

27022011000001108: Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83749701000001118 Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83749801000001110 Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Is a Quinagolide 75microgram tablets true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Is a Quinagolide 75microgram tablets false Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Is a Product containing precisely quinagolide 75 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has active ingredient Quinagolide false Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has specific active ingredient Quinagolide hydrochloride false Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Has specific active ingredient Quinagolide hydrochloride true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) 30 tablet Has AMP True Quinagolide 75microgram tablets (Icarus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start